Pearson's correlation coefficients analysis between immuno-PET signals and survival in ICI and control groups.</p
Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for glioblast...
Immune responses are important for efficient tumor elimination, also in immune privileged organs suc...
PURPOSE: Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for ...
Immuno-PET of 89Zr-DFO-CD69 Ab as a prognostic predictor after ICI treatment in a GBM mouse model. S...
Equilibrium dissociation constants of anti-CD69 Abs clone CD69.2.2 and H1.2F3.</p
Kinetics of activation markers on T cells following ICI treatment. Mice with intracranial GL261 glio...
Immuno-PET of 89Zr-DFO-CD69 Ab visualizes the TME after ICI treatment in a GBM mouse model. Mice wer...
ICIs influence T-cell distribution in tumor and spleen. Mice (n = 28) were inoculated with GL261 cel...
CD69 expression increases on TILs following ICI treatment in patients with GBM. A–C, scRNA-seq analy...
Glioblastoma (GBM) is an aggressive, highly malignant brain tumor with a very poor prognosis, notwit...
Objectives: Immunostimulatory therapies using immune checkpoint blockers show clinical activity in a...
Contrast-enhanced MRI is typically used to follow treatment response and progression in patients wit...
Although immunotherapeutic strategies are emerging as adjunctive treatments for cancer, sensitive me...
Immune checkpoint inhibitors and related molecules can achieve tumour regression, and even prolonged...
Objectives: Immunostimulatory therapies using immune checkpoint blockers show clinical activity in a...
Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for glioblast...
Immune responses are important for efficient tumor elimination, also in immune privileged organs suc...
PURPOSE: Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for ...
Immuno-PET of 89Zr-DFO-CD69 Ab as a prognostic predictor after ICI treatment in a GBM mouse model. S...
Equilibrium dissociation constants of anti-CD69 Abs clone CD69.2.2 and H1.2F3.</p
Kinetics of activation markers on T cells following ICI treatment. Mice with intracranial GL261 glio...
Immuno-PET of 89Zr-DFO-CD69 Ab visualizes the TME after ICI treatment in a GBM mouse model. Mice wer...
ICIs influence T-cell distribution in tumor and spleen. Mice (n = 28) were inoculated with GL261 cel...
CD69 expression increases on TILs following ICI treatment in patients with GBM. A–C, scRNA-seq analy...
Glioblastoma (GBM) is an aggressive, highly malignant brain tumor with a very poor prognosis, notwit...
Objectives: Immunostimulatory therapies using immune checkpoint blockers show clinical activity in a...
Contrast-enhanced MRI is typically used to follow treatment response and progression in patients wit...
Although immunotherapeutic strategies are emerging as adjunctive treatments for cancer, sensitive me...
Immune checkpoint inhibitors and related molecules can achieve tumour regression, and even prolonged...
Objectives: Immunostimulatory therapies using immune checkpoint blockers show clinical activity in a...
Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for glioblast...
Immune responses are important for efficient tumor elimination, also in immune privileged organs suc...
PURPOSE: Dendritic cell (DC) vaccines have recently emerged as an innovative therapeutic option for ...